Login

LAVA Therapeutics NV SEC Filings

Filed On Filing
16 Dec 2025 15-12G
21 Nov 2025 25-NSE/A
21 Nov 2025 S-8 POS
21 Nov 2025 S-8 POS
21 Nov 2025 SC 14D9/A
21 Nov 2025 SC TO-T/A
21 Nov 2025 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
17 Nov 2025 Form 4: Noble James, Director

Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Powell Fred M, Chief Financial Officer

Returned 65,000 shares to the issuer · Disposed of 124,700 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Wadlinger Mary E., Director

Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Oliger Christy J., Director

Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Kiener Peter A, Director

Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Backstrom Jay T., Director

Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Wilson Karen J, Director

Returned 10,000 shares to the issuer · Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Dhingra Kapil, Director

Returned 30,000 shares to the issuer · Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)

17 Nov 2025 Form 4: Hurly Stephen A, Director

Returned 5,000 shares to the issuer · Disposed of 335,100 Share Options (Right to Buy) (Disposition to Issuer)

13 Nov 2025 SC 14D9/A
13 Nov 2025 SC TO-T/A
13 Nov 2025 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Changes in Control of Registrant +1 more
10 Nov 2025 SC 14D9/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support